Company Profiles

driven by the PitchBook Platform

Anokion

Description

Provider of antigen-specific immunotherapy. The company offers antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and to treat autoimmune and allergic diseases.

2012

Founded

PRIVATE

Status

11-50

Employees

Corporate

Latest Deal Type

$45M

Latest Deal Amount

$82.5M

Total Amount Raised

Description

Provider of antigen-specific immunotherapy. The company offers antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and to treat autoimmune and allergic diseases.

Website:

www.anokion.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Biotechnology

Primary Office

EPFL Innovation Park-L Chemin de la Dent d'Ochoe 1A 1024 EcublensSwitzerland +41 (0)21 693 7237
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Anokion's full profile, request a free trial.

Anokion Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Anokion Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
CelgeneCorporationMinority000 0000000 0000
EPFL Innovation ParkAccelerator/IncubatorMinority000 0000000 0000
Novartis Venture FundsCorporate Venture CapitalMinority000 0000000 0000
NovoCorporate Venture CapitalMinority000 0000000 0000
Versant VenturesVenture CapitalMinority000 0000000 0000
Celgene Corporation
EPFL Innovation Park Accelerator/Incubator
Novartis Venture Funds Corporate Venture Capital
Novo Corporate Venture Capital
Versant Ventures Venture Capital

Anokion Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Jens Kurth Ph.DChief Technology Officer
David Lowin JDCo-Founder & Chief Legal Officer
Jeffrey Hubbell Ph.DCo-Founder, Board Member & Chief Scientific Officer
Kristen Lorentz Ph.DCo-Founder & Director, Research
Stephan Kontos Ph.DCo-Founder & Vice President, Research
Jens Kurth Ph.D Chief Technology Officer
David Lowin JD Co-Founder & Chief Legal Officer
Jeffrey Hubbell Ph.D Co-Founder, Board Member & Chief Scientific Officer
Kristen Lorentz Ph.D Co-Founder & Director, Research
Stephan Kontos Ph.D Co-Founder & Vice President, Research

Anokion Board Members (6)

NameRepresentingRoleSinceContact
Info
Andre MuellerSelfBoard Member000 0000
Florent GrosNovartis Venture FundsManaging Director000 0000
Harry WeltenSelfBoard Member000 0000
Jack Bech NielsenNovoSenior Partner, Ventures000 0000
Michael Clayman MDSelfBoard Member000 0000
Andre Mueller Board Member Self
Florent Gros Managing Director Novartis Venture Funds
Harry Welten Board Member Self
Jack Bech Nielsen Senior Partner, Ventures Novo
Michael Clayman MD Board Member Self
Request full access to PitchBook